Baxter Healthcare is a finished-dose manufacturer based in United States. It holds 3 active US drug master files across a filed portfolio of 3 molecules. Its filings concentrate with MEDSAFE (NZ), US FDA and MHRA (UK). Its GMP standing is certified by MHRA (UK), ANVISA (Brazil) and US FDA, among 4 authorities. Its most recent recorded inspection, by US FDA, closed on 29 September 2025 as OAI.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Hayward CA 94545, United Arab Emirates | Not on file |
| THETFORD, United Kingdom | Not on file |
| OXFORD, United Kingdom | Not on file |
| CROYDON, United Kingdom | Not on file |
| NORTHAMPTON, United Kingdom | Not on file |
| READING, United Kingdom | Not on file |
6 further sites are on record.
| Molecule | Regulators | Docs |
|---|---|---|
| Cyclophosphamide | US FDA | 1 |
| Ifosfamide | US FDA | 1 |
| Mesna | US FDA | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| MEDSAFE (NZ) | 351 | None |
| US FDA | 323 | 3 |
| MHRA (UK) | 114 | 16 |
| DH (HK) | 53 | None |
| HSA (SG) | 44 | 3 |
| DAV (Vietnam) | 25 | None |
| ANVISA (Brazil) | None | 4 |
Choose your molecules and target markets. Baxter Healthcare comes back tiered against every other supplier able to file there.
Start for free